Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.)(Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.))

概要

基本信息

药物类型

预防性疫苗

别名

Influenza A virus H5N1 vaccine (Denka Seiken Co., Ltd.)、Adsorbed Influenza Vaccine

靶点-

作用方式

刺激剂

作用机制

免疫刺激剂

治疗领域

感染呼吸系统疾病

在研适应症

甲型流感病毒感染

非在研适应症-

原研机构

Denka Seiken Co., Ltd.

在研机构

Denka Seiken Co., Ltd.

非在研机构-

权益机构-

最高研发阶段批准上市

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) 相关的临床试验

JPRN-jRCT2080221139

/ Unknown status临床2/3期

A Phase II/III, Randomized, Double-Blind, Parallel-Group Study to Assess the Safety and Immunogenicity of Intramuscular A-04-01D (H5N1 influenza vaccine) in Healthy Adult Japanese Volunteers

开始日期2010-06-28

申办/合作机构

Denka Seiken Co., Ltd.

100 项与 Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) 相关的临床结果

登录后查看更多信息

100 项与 Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) 相关的转化医学

登录后查看更多信息

100 项与 Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) 相关的专利（医药）

登录后查看更多信息

1

项与 Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) 相关的文献（医药）

Virologie

Adsorbirovannaia grippoznaia sub''edinichnaia (AGS)vaktsina: poluchenie i kharakteristika.

Article

作者: Konstantinov, V K ; Shapiro, N I ; Shpiliuk, G F ; Zhukova, T Ia ; Entina, N N

Experimental batches of adsorbed subunit influenza vaccine were prepared from the envelope of glycoprotein antigens separated from the influenza virion by treatment with a cationic detergent (cetyltrimethylammonium bromide). Purified and concentrated influenza virus strains A(H1N1) and A(H3N2) were obtained by gradient centrifugation; additional purification, with a view to removing ovalbumin and structural components of the chorioallantoic membrane, was achieved by gelfiltration. The composition and biological properties of the vaccine are described.

100 项与 Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) 相关的药物交易

登录后查看更多信息